Jump Financial, LLC Atreca, Inc. Transaction History

Jump Financial, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.61 - $5.2 $58,604 - $189,280	-36,400 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.87 - $6.29 $61,992 - $135,864	21,600 Added 145.95%	36,400 $110,000
Q3 2021 Nov 12, 2021	BUY	$4.91 - $9.07 $72,668 - $134,236	14,800 New	14,800 $92,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.